York Capital Management Global Advisors’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-156,415
Closed -$4.67M 89
2015
Q4
$4.67M Sell
156,415
-176,984
-53% -$5.97M 0.07% 77
2015
Q3
$10.5M Sell
333,399
-312,330
-48% -$15.2M 0.14% 69
2015
Q2
$31.2M Sell
645,729
-179,318
-22% -$7.56M 0.26% 63
2015
Q1
$35.8M Buy
825,047
+149,450
+22% +$5.37M 0.25% 72
2014
Q4
$17.8M Buy
+675,597
New +$14.8M 0.16% 70

Other funds holding PGEN

York Capital Management Global Advisors's PGEN Position: Q1 2016 in Review

York Capital Management Global Advisors sold out of Precigen (PGEN) in Q1 2016, closing a stake of 156,415 shares — an estimated $4.67M sold.

York Capital Management Global Advisors first reported a position in PGEN in Q4 2014 and held it in 5 quarters. The position peaked at $35.8M in Q1 2015. 191 funds tracked by Wall St. Rank hold PGEN as of Q1 2016.

  • York Capital Management Global Advisors reported no remaining Precigen position as of Q1 2016 after selling out during the quarter.
  • York Capital Management Global Advisors sold 156,415 Precigen shares in Q1 2016, an estimated $4.67M.
  • York Capital Management Global Advisors first reported a position in Precigen in Q4 2014 and held it in 5 quarters.
  • York Capital Management Global Advisors's Precigen position peaked at $35.8M in Q1 2015.
  • 191 funds tracked by Wall St. Rank held Precigen as of Q1 2016.

Based on York Capital Management Global Advisors's 13F filing for Q1 2016, filed 16 May 2016.